Sickle cell disease contraception — DFSRH MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — POP, implant or intrauterine method based on preferences and eligibility
Many progestogen-only and intrauterine methods can be considered in sickle cell disease, with individualised assessment of bleeding, pain and thrombosis risk. CHC may be less suitable if avoiding oestrogen and depending on risk profile. Withdrawal and monthly EC are less reliable, and sterilisation is not the sole safe approach. The pearl is to avoid assuming complex chronic disease means no reversible options exist.
Reference: UKMEC 2025; FSRH Guideline: Contraception for Women with Medical Conditions